#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Central nervous system lymphoma Acute myeloid leukaemia recurrent Oesophageal squamous cell carcinoma stage III Mitochondrial DNA depletion Hereditary motor and sensory neuropathy Multifocal motor neuropathy Hereditary haemorrhagic telangiectasia Autoimmune haemolytic anaemia Desmoplastic small round cell tumour Diffuse large B-cell lymphoma Eosinophilic oesophagitis Haemophilia B without inhibitors Huntington's disease Staphylococcal infection Intracranial germ cell tumour More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Trials in Disease Breast angiosarcoma – Basic Information Nodal marginal zone B-cell lymphoma – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Treatment Alternating hemiplegia of childhood – Life with Disease Turner’s syndrome – Trials in Disease Pulmonary fibrosis – Trials in Disease Osteosarcoma – Trials in Disease Mantle cell lymphoma – Basic Information Mast cell activation syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Namilumab FIBRIN NVG-2089 Sonidegib Raxtozinameran Risedronate Sodium INSULIN DEGLUDEC Teverelix Nebivolol Sorafenib Tosilate Histamine Dihydrochloride Linvoseltamab ATUMELNANT Simoctocog Alfa PHENTOLAMINE MESILATE Atropine Sulfate Regn7075 Paracetamol Dc Vibosameran Calcium Pantothenate Bp More therapies…

    Learn about Your Condition

    Malignant melanoma stage IV Oesophagectomy Prostate cancer recurrent Intellectual disability Actinic cheilitis Deafness bilateral Skin wrinkling Thromboembolectomy Postoperative wound infection Kaposi's sarcoma Mixed dementia Pharyngeal cancer stage III Dyspepsia Thalassaemia alpha Tuberculosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effectiveness and Safety of Chikungunya Vaccine (VLA-1553) for People at Risk of Severe Chikungunya in La Réunion

    Recruiting

    3 1 1 1
    France

  • Study on the Effectiveness and Safety of Sepofarsen for Patients with Leber Congenital Amaurosis Due to a Specific Genetic Mutation

    Recruiting

    3 1
    Investigated Drugs:
    • SEPOFARSEN
    Belgium France Germany The Netherlands Spain

  • Study of Ivonescimab for Treating Relapsed Pleural Mesothelioma in Patients After Immunotherapy and Chemotherapy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pleural mesothelioma malignant
    Investigated Drugs:
    • Ivonescimab
    France

  • Study on the Effects of Darolutamide and Drug Combination for Patients with Metastatic Hormone-Naïve Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Abiraterone
    • Apalutamide
    • Darolutamide
    Belgium Croatia Czechia Denmark France Ireland +4

  • Study on the Effectiveness and Safety of GAL-101 Eye Drops for Patients with Geographic Atrophy from Age-Related Macular Degeneration

    Recruiting

    2 1
    Investigated Drugs:
    • SODIUM (R)-2-(2-AMINO-3-(1H-INDOL-3- YL)PROPANAMIDO)-2-METHYLPROPANOATE-PROPAN-2-OL
    France Germany Ireland Italy

  • Study on the Safety of Difelikefalin for Adolescents with Itching Due to Chronic Kidney Disease on Hemodialysis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Difelikefalin
    Greece Italy Portugal Spain
Previous Page
1 … 235 236 237 238 239 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!